Alcidion (ASX:ALC) has raised funds via a placement
Alcidion Group Ltd. has raised funds to accelerate its growth strategy.
Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. It integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety, increasing productivity amongst clinical staff through messaging applications, and data capture and interpretation.
Oaklins’ team in Australia acted as Alcidion’s lead manager to raise money via an institutional placement.
Talk to the deal team
Related deals
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreGroupe JVS has acquired Abelium Collectivités
Groupe JVS has acquired Abelium Collectivités, which was subsequently rebranded as Familea. The transaction, supported by CAPZA as a minority shareholder and Bpifrance, strengthens Groupe JVS’s strategy in the childcare and family services sector while expanding its offering to local public sector stakeholders.
Learn more